Biotech Timing and Trial Design: A Case Study in Value Creation
A biotech case study from approval to aquisition — how trial design and drug delivery choices shaped Verona Pharma’s $10B buyout by Merck and influenced both investor outcomes and market impact.
Beyond Approval: The Hidden Risk in Biotech Stocks
What happens after regulatory approval? The overlooked risks biotech companies face post-approval—and why even promising drugs can stumble after reaching the market.
Tariff Shocks and Portfolio Lessons: Navigating Uncertainty in a Volatile Market
A week of rising tariffs and falling confidence showed how market turbulence can test investors — and prompted me to rethink my own long-term strategy.
The short story of my website and personal brand
After experimenting with social media platforms, I found their formats a bit limiting. I wanted a space that offered more creative freedom – a place to fully express and unify my diverse roles and interests in science, art and design. This led
